Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) have announced that the National Institute for Health and Care Excellence (NICE), a non-departmental public body of the Department of Health in the United Kingdom, issued a second draft guidance on the use of PIXUVRI(®) (pixantrone) as a...
New Findings Show Inhibiting Powerful Protein with New Agents May Supply Broad Benefit for Lymphoma Patients A soon-to-be-tested class of drug inhibitors were predicted to help a limited number of patients with B-cell lymphomas with mutations affecting the EZH2 protein. However, a research team...
Primary effusion lymphoma (PEL) is a rare, fatal form of aggressive B-cell lymphoma caused by Kaposi's sarcoma-associated herpesvirus (KSHV). The disease most commonly occurs in immunocompromised patients, such as those with HIV and the elderly. Because current treatment options are not...
New research, presented at the 54th Annual Meeting of the American Society of Hematology (ASH), has identified important associations between Plasmodium falciparum (Pf) malaria and endemic Burkitt Lymphoma (eBL) that may help researchers identify young children who are more susceptible to eBL...
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma. A phase 1 clinical trial of the drug crizotinib achieved...
Scientists at Fox Chase Cancer Center in Philadelphia have come one step closer to developing the first treatment to target a key pathway in lymphoma. The new findings was announced at the AACR Annual Meeting 2012. "It's an exciting time to be involved in lymphoma treatment and research," says...
"Twinning" U.S.-Based And Rwandan Physicians Improves Lymphoma Outcomes In Children
In an African county lacking any specialists in children's cancers, a team approach that "twins" Rwandan physicians with Boston-based pediatric oncologists has shown it can deliver expert, curative care to young...
"If Hamlet Give The First Or Second Hit", The Development Of Burkitt's Lymphoma
Although Burkitt's lymphoma is thankfully fairly rare in the general population, it is the most common form of malignancy in children in Equatorial Africa and is very frequent in immunocompromised persons, such as...
An experimental vaccine developed by researchers at the University of Pennsylvania's schools of Medicine and Veterinary Medicine is the first veterinary cancer vaccine of its kind that shows an increase in survival time for dogs with spontaneous non-Hodgkin's lymphoma. The work shows for the...
Clinical research has shown that recurrence of Mantle Cell Lymphoma, a variant of malignant lymphoma, can be reduced by almost 50% in patients who receive maintenance treatment with the antibody rituximab. These results are presented by Dr Hanneke Kluin-Nelemans at the 16th Congress of the...
Women who have saline and silicone gas-filled breast implants have a higher risk of developing ALCL (anaplastic large cell lymphoma), an aggressive type of non-Hodgkin lymphoma that is generally of the T-cell type. The cancer may appear in the liver, lungs, soft tissues, bones, skin, and/or...
I have a 22 month old (very old) pet mouse named Portia. She has been getting scabs all over her body recently and I've been giving her vitamin supplements and fish oil. Now, as she has begun loosing weight, I've noticed two tumors under her chin (glands), one on her back leg (above knee) and...
Experimental drug Brentuximab Vedotin (SGN-35) achieved tumor volume reductions in 94% of Relapsed or Refractory Hodgkin Lymphoma patients while 34% of them achieved complete remission, Seattle Genetics reported after completing a Pivotal Clinical Trial. The company expects to submit the...
J. Eric Bubbers, PhD, of the Saban Research Institute at Childrens Hospital Los Angeles, has received a $410,000 grant from Phase One Foundation. The award will fund a "first in childhood leukemia" multi-site study in children with relapsed or refractory acute lymphocytic leukemia (ALL) or acute...
Three researchers who are recipients of a collaborative grant from the Samuel Waxman Cancer Research Foundation have developed a new type of drug designed to kill non-Hodgkin lymphoma tumor cells. The breakthrough could lead to potential non-toxic therapies for cancer patients. The...
UroToday.com - The incidence of testicular cancer (TC) and Hodgkin lymphoma (HL) has increased recently. Although improved chemotherapeutic regimens have augmented survival in men with these malignancies, they are associated with a negative impact on reproductive health, including a decrease in...
I noticed a hard painless lymph node on the front of my shoulder right beside my arm-pit about 9 months ago and pointed it out to my Dr... all he said was "thats interesting" and told me to get a mamogram. (Considering my shoulder will not fit in a mamogram I don't see how this would do anything...
...started acting strange.? She went out of her mind hallucinating and saying crazy things, does this always happen just can't get that image out of my mind. Anyone have an answer for me.
I've got a grandmother with these, what are the odds that this would happen? I know that this is rare, but are there other people who have developed this?